Latest News

Journal Articles

Brain and neurologic

Checkpoint blockade immunotherapy doubles survival for melanoma brain metastases patients

Glioblastoma vaccine yields promising interim survival results in Phase III trial

Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports


Promising Phase 1b clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer

IMpassion130: first positive Phase III immunotherapy study in TNBC

TAILORx: a practice-changing breast cancer trial


ASCO18: PRODIGE 7 demonstrates that HIPEC may not be necessary for CRC patients

ASCO18: Day 2 update

ASCO18: MSI-H tumor patients more likely to have Lynch Syndrome, genomic study demonstrates


Sodium thiosulphate halves hearing loss in children following cancer treatment

ASCO18: Is surgery necessary for advanced kidney cancer?

Nivolumab + ipilimumab combo approved as first-line treatment for advanced renal cell carcinoma


Conference Chair highlights: World Congress on Gastrointestinal Cancer

ESMO WCGI: Trifluridine and tipiracil show promise as metastatic gastric cancer treatment in Phase III trial

New blood test could detect eight types of cancer


NICE approves atezolizumab for advanced bladder cancer patients on the NHS

Breakthrough method to diagnose prostate cancer developed

Researchers uncover 80 potential ways of targeting prostate cancer


Ovarian cancer progression delayed by Lynparza® treatment

Vaccine success for cervical cancer: study reports fall in HPV infections

Cause of resistance to olaparib and other PARP inhibitors identified

Head and neck

The importance of a multidisciplinary team in the care of head and neck cancer

The importance of sentinel lymph node biopsies in the diagnosis of head and neck cancer

ASCO18: High dose of Nexium® with aspirin reduces risk of developing esophageal cancer


Factors associated with receipt of hematopoietic cell transplantation for acute lymphoblastic leukemia

First-time evidence that individuals at risk of developing AML can be identified, years before diagnosis

Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA


Researchers create first comprehensive atlas of lung tumor cells

Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice

NICE approve Alecensa as first-line treatment for ALK-positive NSCLC


ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer

ESMO WCGI: Adjuvant FOLFIRINOX new standard of care for pancreatic cancer

ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer


Trace levels of CTCs could spot early signs of prostate cancer treatment ineffectiveness

Key mechanism that drives hormone therapy resistance in prostate cancer uncovered

Genetic test could identify prostate cancer patients who are most likely to benefit from immunotherapy

Rare tumors

Osteoblastoma genetic marker shows promise for identifying aggressive tumors

Practice-changing breakthrough made for rare cancer

First-in-world robot-assisted spinal surgery performed


Checkpoint blockade immunotherapy doubles survival for melanoma brain metastases patients

Deciding when to stop immunotherapy: exploring KEYNOTE-006 data

In Focus: skin cancer